FDA Extends Shelf Life of Johnson & Johnson’s COVID-19 Vaccine

FDA Extends Shelf Life of Johnson & Johnson’s COVID-19 Vaccine
Banners advertise the availability of the Johnson & Johnson and Pfizer COVID-19 vaccines at a vaccination site in Los Angeles, Calif., on July 22, 2021. Damian Dovarganes/AP Photo
Tom Ozimek
Tom Ozimek
Reporter
|Updated:

The Food and Drug Administration (FDA) has agreed to extend the shelf life on Johnson & Johnson’s single-shot COVID-19 vaccine from four-and-a-half months to six months.

In a July 28 concurrence letter (pdf), the FDA said Johnson & Johnson had provided sufficient data to support the extension of the company’s vaccine to six months, including for already expired batches, provided they have been stored within the required temperature range of between 36–46 degrees Fahrenheit (2–8 degrees Celsius).
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics